Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 160, Issue 3, Pages 480-498Publisher
WILEY
DOI: 10.1111/j.1476-5381.2010.00735.x
Keywords
cannabinoid; endocannabinoid; anandamide; 2-arachidonoylglycerol; neuroprotective; anti-inflammatory
Categories
Funding
- NIDA NIH HHS [P50 DA005274, R01 DA009978] Funding Source: Medline
- NINDS NIH HHS [R21 NS041639] Funding Source: Medline
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS041639] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005274, R01DA009978] Funding Source: NIH RePORTER
Ask authors/readers for more resources
This article is part of a themed issue on Cannabinoids. To view the editorial for this themed issue visit http://dx.doi.org/10.1111/j.1476-5381.2010.00831.x.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
